Detalhe da pesquisa
1.
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity.
Nature
; 623(7989): 1034-1043, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993715
2.
Role of B cells in immune-related adverse events following checkpoint blockade.
Immunol Rev
; 318(1): 89-95, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421187
3.
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study.
Clin Infect Dis
; 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38801746
4.
Tissue-resident memory-like T cells in tumor immunity: Clinical implications.
Semin Immunol
; 49: 101415, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33011063
5.
Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.
Blood
; 137(26): 3604-3615, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649772
6.
The immune system in multiple myeloma and precursor states: Lessons and implications for immunotherapy and interception.
Am J Hematol
; 98 Suppl 2: S4-S12, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194782
7.
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
PLoS Med
; 17(11): e1003323, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147277
8.
Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling.
Biol Blood Marrow Transplant
; 26(10): e247-e255, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589921
9.
Daratumumab in multiple myeloma.
Cancer
; 125(14): 2364-2382, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951198
10.
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
Cancer
; 125(3): 416-423, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30332496
11.
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.
N Engl J Med
; 374(6): 555-61, 2016 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26863356
12.
It takes T to tango: immunotherapy in MM.
Blood
; 139(9): 1259-1260, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238890
13.
Type II NKT Cells and Their Emerging Role in Health and Disease.
J Immunol
; 198(3): 1015-1021, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28115591
14.
MGUS to myeloma: a mysterious gammopathy of underexplored significance.
Blood
; 128(23): 2599-2606, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27737890
15.
Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy.
Blood
; 126(22): 2475-8, 2015 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26468228
16.
Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation.
Blood
; 125(8): 1256-71, 2015 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25499455
17.
Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets.
Blood
; 125(26): 4042-51, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869284
18.
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo.
J Immunol
; 194(3): 950-9, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25539810
19.
Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).
Blood
; 123(1): 78-85, 2014 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24144643
20.
Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk.
J Immunol
; 193(5): 2297-305, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25080481